Sell-side analysts on Wall Street are anticipating that Enzo Biochem, Inc. (NYSE:ENZ) will report earnings of $-0.06 per share when the company issues their quarterly report today. This is the consensus EPS number according to data from Zack’s Research. How the estimated EPS differs from the actual earnings number is what investors will be paying particularly close attention to.
Most recently Enzo Biochem, Inc. (NYSE:ENZ) posted a surprise factor of 33.33%. The actual number was $0.02 away from the Zacks consensus immediately prior to the actual release. A significant surprise factor can lead to stock volatility and swings in the share price in the hours and days following the earnings report.
Projected Stock Movement
Research brokerage firms covering shares of Enzo Biochem, Inc. (NYSE:ENZ) are anticipating on a consensus basis that the stock will reach $8 within the next 52 weeks. Of the analysts providing short term targets, the most bullish analyst has a $8 target on the stock. On the other end, the most conservative has a short term target of $8. This is based on the 1 analysts taken into consideration by Zacks. The consensus price target was last revised on 2016-06-09.
Zacks also provides a simplified scale for analyst recommendations. They use a one to five scale where they translate brokerage firm Buy/Sell/Hold recommendations into an average broker rating. A low number in the 1-2 range typically indicates a Buy, 3 represents a Hold and 4-5 represents a consensus Sell rating. Enzo Biochem, Inc. (NYSE:ENZ) currently has an ABR of 1 heading into today’s announcement. This number is also based on the 1 sell-side firms polled by Zacks
This article is informational purposes only and should not be considered a recommendation to buy or sell the stock